SEARCH

SEARCH BY CITATION

References

  • 1
    Aaronson S.A. (1991) Growth factors and cancer. Science 254, 1146 1153.
  • 2
    Aiello L.P., Avery R.L., Arrigg P.G.et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480 1519.
  • 3
    Alonsa-Varona A., Palomares T., Bilbao P., Calle Y., Castro B., Barbera-Guillem E. (1996) Tumor–host interaction in non-random metastatic pattern distribution. Bull. Du Cancer 83, 27 38.
  • 4
    Arap W., Pasqualini R., Ruoslahti E. (1998) Cancer treatment targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377 380.
  • 5
    Baggetto L.G. (1997) Biochemical, genetic, and metabolic adaptations of tumors cells that express the typical multidrug-resistance phenotype. Reversion by new therapies. J. Bioenerg. and Biomemb. 29, 401 413.
  • 6
    Bearer E.L. & Orci L. (1985) Endothelial fenestral diaphragms: a quick-freeze, deep-etch study. J. Cell Biol. 100, 418 428.
  • 7
    Belloni P.N., Carney D.H., Nicolson G.L. (1992) Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvas. Res. 43, 20 45.
  • 8
    Berkman R.A., Merrill M.J., Reinhold W.C.et al (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 91, 153 159.
  • 9
    Bohling T., Hatva E., Kujala M., Claesson-Welsh L., Alitalo K., Haltia M. (1996) Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J. Neuropathol. Exp. Neurol. 55, 522 527.
  • 10
    Breier G., Albrecht U., Sterrer S., Risau W. (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521 532.
  • 11
    Breier G. & Risau W. (1996) The role of vascular endothelial growth factor in blood vessel formation. Trend. Cell Biol. 6, 454 456.
  • 12
    Brogi E., Schatteman G., Wu T.et al (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 2, 469 476.
  • 13
    Brooks P.C., Montgomery A.M.P., Rosenfeld M.et al (1994) Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157 1164.
  • 14
    Brown L.F., Berse B., Tognazzi K.et al (1992a) Vascular permeability factor mRNA and protein expression in human kidney. Kidney Internatl. 42, 1457 1461.
  • 15
    Brown L.F., Yeo K.-T., Berse B.et al (1992b) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375 1379.
  • 16
    Brown L.F., Berse B., Jackman R.W.et al (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its cognate receptors in breast cancer. Hum. Pathol. 26, 86 91.
  • 17
    Brown J.M. & Giaccia A.J. (1998) The unique physiology if solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408 1416.
  • 18
    Bruns R.R. & Palade G.E. (1968a) Studies on blood capillaries I. General organization of blood capillaries in muscle. J. Cell Biol. 37, 244 276.
  • 19
    Bruns R.R. & Palade G.E. (1968b) Studies on blood capillaries II. Transport of ferritin molecules across the wall of muscle capillaries. J. Cell Biol. 37, 277 299.
  • 20
    Claffey K.P., Brown L.F., Del Aguila L.F.et al (1996) Expression of vacular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56, 172 181.
  • 21
    Clementi F. & Palade G.E. (1969) Intestinal capillaries. I. Permeability to peroxidase and ferritin. J. Cell Biol. 41, 33 58.
  • 22
    De Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor . Science 255, 989 991.
  • 23
    Dejana E. (1996) Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis. J. Clin. Invest. 98, 1949 1953.
  • 24
    Dellian M., Witwer B.P., Salehi H.A., Yuan F., Jain R.K. (1996) Quantitation and physiological characterization of angiogenic vessels in mice. Am. J. Path. 149, 59 71.
  • 25
    Detmar M., Brown L.F., Claffey K.P.et al (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141 1146.
  • 26
    Dobrogowska D.H., Lossinsky A.S., Tarnawski M., Vorbrodt A.W. (1998) Increased blood–brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J. Neurocytol. 27, 163 173.
  • 27
    Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W. (1998a) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Science 111, 1853 1865.
  • 28
    Esser S., Wolburg K., Wohlburg H., Breier G., Kurzchalia T., Risau W. (1998b) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140, 947 959.
  • 29
    Farquhar M.G. & Palade G.E. (1961) Glomerular permeability II. Ferritin transfer across the glomerular capillary wall in nephrotic rats. J. Exp. Med. 114, 699 716.
  • 30
    Feng D., Nagy J.A., Hipp J., Pyne K., Dvorak H.F., Dvorak A.M. (1997) Reinterpretation of endothelial cell gaps induced by vascoactive mediators in guinea-pig, mouse and rat: many are transcellular pores. J. Physiol. 504, 747 761.
  • 31
    Ferrara N. & Davis-Smyth T. (1997) The biology of vascular endothelial growth factor. Endocrine Rev. 18, 4 25.
  • 32
    Ferrara N. & Henzel W.J. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Comm. 161, 851 858.
  • 33
    Folkman J. (1997) Angiogenesis and angiogenesis inhibition: an overview. Exs 79, 1 8.
  • 34
    Folkman J. & Shing Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10931 10934.
  • 35
    Fong G.-H., Klingensmith J., Wood C.R., Rossant J., Breitman M.L. (1996) Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium. Developmental Dynamics 207, 1 10.
  • 36
    Fong G.-H., Rossant J., Gertsenstein M., Breitman M.L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66 70.
  • 37
    Fu X., Roberts W.G., Nobile V., Shapiro R., Kamps M. (1998) Angiogenin-3, a target gene of E2a-Pbx1 in NIH3T3 fibroblasts, is a new angiogenic member of the angiogenin family. J. Cell Biol. in press.
  • 38
    Fukumura D., Salehi H.A., Witwer B., Tuma R.F., Melder R.J., Jain R.K. (1995) Tumor necrosis factor α-induced leukocyte adhesion in normal and tumor vessels: Effect of tumor type, transplantation site, and host strain. Cancer Res. 55, 4824 4829.
  • 39
    Fukumura D., Yuan F., Monsky W.L., Chen Y., Jain R.K. (1997) Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am. J. Path. 151, 679 688.
  • 40
    Gerber H., Condorelli F., Park J., Ferrara N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659 23667.
  • 41
    Gladson C.L. (1996) Expression of integrin αvβ3 in small blood vessels of glioblastoma tumors. J. Neuropathol. Exp. Neurol. 55, 1143 1149.
  • 42
    Granger D.N., Granger J.P., Brace R.A., Parker R.E., Taylor A.E. (1979) Analysis of the permeability characteristics of cat intestinal capillaries. Circ. Res. 44, 335 344.
  • 43
    Gutman M., Singh R.K., Xie K., Bucana C.D., Fidler I.J. (1995) Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res. 55, 2470 2475.
  • 44
    Hanahan D. & Folkman J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353 364.
  • 45
    Hobbs S.K., Monsky W.L., Yuan F.et al (1998) Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 95, 4607 4612.
  • 46
    Huang X., Molema G., King S., Watkins L., Edginton T.S., Thorpe P.E. (1997) Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275, 547 550.
  • 47
    Jackson M.R., Carney E.W., Lye S.J., Ritchie J.W. (1994) Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 15, 341 353.
  • 48
    Jain R.K. (1988) Determinants of blood flow: a review. Cancer Res. 48, 2641 2658.
  • 49
    Jain R.K. (1996) Delivery of molecular medicine to solid tumors. Science 271, 1079 1080.
  • 50
    Jeltsch M., Kaipainen A., Joukov V.et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423 1425.
  • 51
    Joris I., Cuenoud H.F., Doern G.V., Underwood J.M., Majno G. (1990) Capillary leakage in inflammation. Am. J. Path. 137, 1353 1363.
  • 52
    Kerbel R.S. (1990) Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv. Cancer Res. 55, 87 132.
  • 53
    Kevil C.G., Payne D.K., Mire E., Alexander J.S. (1998) Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J. Biol. Chem. 273, 15099 15103.
  • 54
    Koch A.E., Harlow L.A., Haines G.K.et al (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152, 4149 4156.
  • 55
    Kohn S., Nagy J.A., Dvorak H.F., Dvorak A.M. (1992) Pathways of macromolecular tracer transport across venules and small veins. Lab. Invest. 67, 596 607.
  • 56
    Laitinen M., Ristimaki A., Honkasalo M., Narko K., Paavonen K., Ritvos O. (1997) Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 138, 4748 4756.
  • 57
    Leunig M., Yuan F., Menger M.D.et al (1992) Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T: in SCID mice. Cancer Res. 52, 6553 6560.
  • 58
    Levick J.R. & Smaje L.H. (1987) An analysis of the permeability of a fenestrae. Microvas. Res. 33, 233 256.
  • 59
    Lin P., Sankar S., Shan S.et al (1998) Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Diff. 9, 49 58.
  • 60
    Lindner V., Majack R., Reidy M. (1990) Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J. Clin. Invest. 85, 2004 2008.
  • 61
    Majno G. & Palade G.E. (1961) Studies on inflammation I. The effect histamine and serotonin on vascular permeability: an electron microscopic study. J. Biochem. Biophys. Cytol. 11, 571 605.
  • 62
    Majno G., Palade G.E., Schoefl G.I. (1961) Studies on inflammation II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J. Biochem. Biophys. Cytol. 11, 607 626.
  • 63
    Mantovani A., Bussolino F., Dejana E. (1992) Cytokine regulation of endothelial cell function. FASEB J. 6, 2591 2599.
  • 64
    McCormick B.A. & Zetter B.R. (1992) Adhesive interactions in angiogenesis and metastasis. Pharmac. Ther. 53, 239 260.
  • 65
    Moore J.V. & West D.C. (1991) Vasculature as a target for anti-cancer therapy. Cancer Cells 3, 100 102.
  • 66
    Morishita K., Johnson D.E., Williams L.T. (1995) A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression . J. Biol. Chem. 270, 27948 27953.
  • 67
    Mustonen T. & Alitalo K. (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129, 895 989.
  • 68
    Nelson J.S., Liaw L.-H., Orenstein A., Roberts W.G., Berns M.W. (1988) Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J. Natl. Canc. Inst. 80, 1599 1605.
  • 69
    Nicolson G.L. (1988) Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev. 7, 143 188.
  • 70
    O'Neill P.M., Bray P.G., Hawley S.R., Ward S.A., Park B.K. (1998) 4-aminoquinolines-past, present, and future: a chemical perspective. Pharmacol. Therap. 77, 29 58.
  • 71
    O'Reilly M.S., Boehm T., Shing Y.et al (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277 285.
  • 72
    Park J.E., Keller G.-A., Ferrara N. (1993) The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317 1326.
  • 73
    Pasqualini R. & Ruoslahti E. (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380, 364 366.
  • 74
    Pasqualini R., Koivunen E., Ruoslahti E. (1997) av integrins as receptors for tumor targeting by circulating ligands. Nature Biotechnol. 15, 542 546.
  • 75
    Peters K.G., De Vries C., Williams L.T. (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. USA 90, 8915 8919.
  • 76
    Peters A., Palay S.L., Webster H. (1991) Blood Vessels. In: The Fine Structure of the Nervous System, Eds A. Peters, S.L. Palay & H. Webster, pp. 344 355. Oxford: Oxford University Press.
  • 77
    Plate K.H., Breier G., Millauer B., Ullrich A., Risau W. (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53, 5822 5827.
  • 78
    Plate K.H., Breier G., Weich H.A., Mennel H.D., Risau W. (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms . Int. J. Cancer 59, 520 529.
  • 79
    Quinn T.P., Peters K.G., Devries C., Ferrara N., Williams L.T. (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533 7537.
  • 80
    Rifkin D.B. & Klagsbrun M. (1987) Angiogenesis: Mechanisms and Pathobiology, Cold Spring Harbor: Cold Spring Harbor Laboratory.
  • 81
    Risau W. (1995) Differentiation of endothelium. FASEB J. 9, 926 933.
  • 82
    Risau W. (1998) Induction of blood–brain barrier endothelial cell differentiation. Ann. NY Acad. Sci. 633, 405 419.
  • 83
    Roberts W.G. & Palade G.E. (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Science 108, 2369 2379.
  • 84
    Roberts W.G. & Palade G.E. (1997) Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57, 765 772.
  • 85
    Roberts W.G., Delaat J., Nagane M., Huang S., Cavenee W.K., Palade G.E. (1998) Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am. J. Path. 153, 1239 1248.
  • 86
    Rostgaard J. & Qvortrup K. (1997) Electron microscope demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvas. Res. 53, 1 13.
  • 87
    Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983 985.
  • 88
    Shalaby F., Rossant J., Yamaguchi T.P.et al (1995) Failure of blood-island and vasculogenesis in Flk-1-deficient mice. Nature 376, 62 66.
  • 89
    Shweiki D., Itin A., Soffer D., Keshet E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843 845.
  • 90
    Shweiki D., Neeman M., Itin A., Keshet E. (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc. Natl. Acad. Sci. 92, 768 772.
  • 91
    Simionescu N. & Palade G.E. (1971) Dextrans and glycogens as particulate tracers for studying capillary permeability. J. Cell Biol. 50, 616 624.
  • 92
    Simionescu M., Ghinea N., Fixman A.et al (1988) The cerebral microvasculature of the rat: structure and luminal surface properties during early development. J. Submicrosc. Cytol. Pathol. 20, 243 261.
  • 93
    Singh R.K., Bucana C.D., Gutman M., Fan D., Wilson M.R., Fidler I.J. (1994) Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Path. 145, 365 374.
  • 94
    Skinner S.A., Tutton P.J.M., O'Brien P.E. (1990) Microvascular architecture of experimental colon tumors in the rat. Cancer Res. 50, 2411 2417.
  • 95
    Stein I., Neeman M., Shweiki D., Itin A., Keshet E. (1995) Stablization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15, 5363 5368.
  • 96
    Strawn L.M., McMahon G., App H.et al (1996) Flk-1 as a target for tumor growth inhibition. Cancer Res. 56, 3540 3545.
  • 97
    Suri C., Jones P.F., Patan S.et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171 1180.
  • 98
    Umansky V., Schirrmacher V., Rocha M. (1996) New insights into tumor–host interactions in lymphoma metastasis. J. Mol. Med. 74, 353 363.
  • 99
    Virgintino D., Robertson D., Monaghan P.et al (1997) Glucose transporter GLUT1 in human brain microvessels revealed by ultrastructural immunocytochemistry. J. Submicrosc. Cytol. Pathol. 29, 365 370.
  • 100
    Weinstat-Saslow D. & Steeg P.S. (1994) Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB Journal 8, 401 407.
  • 101
    Wesseling P., Ruiter D.J., Burger P.C. (1997) Angiogenesis in brain tumors; pathobiological and clinical aspects. J. Neuro-Oncol. 32, 253 265.
  • 102
    Wickham T.J., Haskard D., Segal D., Kovesdi I. (1997) Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation. Cancer Immunol. Immunother. 45, 149 151.
  • 103
    Wingo P.A., Ries L.A., Rosenberg H.M., Miller D.S., Edwards B.K. (1998) Cancer incidence and mortality. 1973–95: a report card for the U.S. Cancer 82, 1197 1207.
  • 104
    Yamaguchi T.P., Dumont D.J., Conlon R.A., Breitman M.L., Rossant J. (1993) flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors . Development 118, 489 498.
  • 105
    Yuan F., Leunig M., Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. (1994a) Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res. 54, 3352 3356.
  • 106
    Yuan F., Salehi H.A., Boucher Y., Vasthare U.S., Tuma R.F., Jain R.K. (1994b) Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54, 4564 4568.
  • 107
    Yuan F., Dellian M., Fukumura D.et al (1995) Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res. 55, 3752 3756.
  • 108
    Zocchi M.R. & Poggi A. (1993) Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas. J. Natl. Canc. Inst. 85, 246 247.